Contracts Finder · Award
Diabetes technology - (Air Liquide)
A public procurement published by Nottingham University Hospitals NHS Trust via Contracts Finder.
- £1.6m
- Award value
- £1.6m
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Award
- Stage
Overview
Direct award, via NHS Supply Chain Framework for Insulin Pumps, Continuous Glucose Monitoring, Closed Loop Insulin Delivery Systems and Associated Products Framework Reference Number: 2021/S 000-014257 URN: 2021/S 000-014257/0911
Key details
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- complete
- CPV classification
- 33615000 — Medicinal products used in diabetes
- Currency
- GBP
- Total award value
- £1,612,800
- Tender value
- £1,612,800
- First published
- 4 Mar 2025
- Last updated
- 4 Mar 2025
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Air Liquide Limited | 02103630 | 26 Apr 2024 | active | £1.6m |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Nottingham University Hospitals NHS Trust
FAQs about this procurement
Who is the buyer for "Diabetes technology - (Air Liquide)"?
Diabetes technology - (Air Liquide) is a UK public-sector procurement published by Nottingham University Hospitals NHS Trust via Contracts Finder.
Has "Diabetes technology - (Air Liquide)" been awarded?
Yes — 1 award is recorded, with a reported total value of £1,612,800. The current lifecycle stage is "Award".
Which suppliers are involved in "Diabetes technology - (Air Liquide)"?
1 supplier is linked: Air Liquide Limited.
What is "Diabetes technology - (Air Liquide)" worth?
The reported award value is £1,612,800.
When was "Diabetes technology - (Air Liquide)" published?
It was first published on 4 Mar 2025 and last updated on 4 Mar 2025, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable